| Product NDC: | 52533-034 | 
| Proprietary Name: | Labetalol HCl | 
| Non Proprietary Name: | Labetalol HCl | 
| Active Ingredient(s): | 5 mg/mL & nbsp; Labetalol HCl | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION, SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 52533-034 | 
| Labeler Name: | Cantrell Drug Company | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER | 
| Start Marketing Date: | 20120223 | 
| Package NDC: | 52533-034-20 | 
| Package Description: | 4 mL in 1 SYRINGE, PLASTIC (52533-034-20) | 
| NDC Code | 52533-034-20 | 
| Proprietary Name | Labetalol HCl | 
| Package Description | 4 mL in 1 SYRINGE, PLASTIC (52533-034-20) | 
| Product NDC | 52533-034 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Labetalol HCl | 
| Dosage Form Name | INJECTION, SOLUTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 20120223 | 
| Marketing Category Name | UNAPPROVED DRUG OTHER | 
| Labeler Name | Cantrell Drug Company | 
| Substance Name | LABETALOL HYDROCHLORIDE | 
| Strength Number | 5 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |